Bank of America looks favorably upon Demant's launch of Oticon Zeal

Favorable analyst coverage of Demant signals that Wall Street views the Oticon Zeal launch as a meaningful commercial catalyst, which may influence the company's R&D investment and competitive positioning in the hearing aid market.